Prescription Drug Monitoring Programs and Opioid-Related Harm
Funded by: National Institute on Drug Abuse
Project dates: April 2016 - January 2020
Principal Investigator: Cerdá, Magdalena

This study examined the relationship between implementation of “best practice” prescription drug monitoring program features and change in the rate of nonfatal and fatal prescription opioid and heroin overdoses in the United States.

Abstract on NIH RePORTER
Related Publications
Martins SS, Ponicki W, Smith N, Rivera-Aguirre A, Davis CS, Fink DS, Castillo-Carniglia A, Henry SG, Marshall BDL, Gruenewald P, Cerda M (2019).
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
International Journal of Drug Policy, 74, 174-180. doi: 10.1016/j.drugpo.2019.10.001. PMCID: PMC6897357.

Cerda M, Ponicki W, Smith N, Rivera-Aguirre A, Davis CS, Marshall BDL, Fink DS, Henry SG, Castillo-Carniglia A, Wintemute GJ, Gaidus A, Gruenewald P, Martins SS (2020).
Measuring relationships between proactive reporting state-level prescription drug monitoring programs and county-level fatal prescription opioid overdoses
Epidemiology, 31 (1), 32-42. doi: 10.1097/EDE.0000000000001123. PMCID: PMC7027962.